Latanoprost + Timolol Generis

Timolol maleate and Latanoprost, the active ingredients in Latanoprost + Timolol Generis, are a non‑selective beta‑blocker and a prostaglandin analog presented as a combination eye‑drop formulation for ocular (topical) use. The product is indicated for the management of open‑angle glaucoma and ocular hypertension by lowering intra‑ocular pressure.

GNH USA supplies Latanoprost + Timolol Generis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Latanoprost + Timolol Generis is used in the ophthalmic therapeutic area to lower intra‑ocular pressure in glaucoma‑related conditions.

- Open‑angle glaucoma: reduces intra‑ocular pressure, helping to prevent optic nerve damage. - Ocular hypertension: lowers elevated eye pressure to reduce risk of progression to glaucoma. - Other forms of glaucoma where pressure reduction is required: provides IOP control as part of a comprehensive treatment plan.

Latanoprost + Timolol Generis may cause ocular and systemic adverse reactions.

Common Side Effects: - Eye irritation or burning sensation. - Blurred vision shortly after instillation. - Conjunctival hyperemia (eye redness). - Increased eyelash growth or darkening of the iris.

Serious or Rare Side Effects: - Severe allergic reaction with swelling of the eyelids or face. - Exacerbation of asthma or chronic obstructive pulmonary disease. - Marked bradycardia or hypotension. - Vision loss due to ocular inflammation.

Before prescribing Latanoprost + Timolol Generis, clinicians should consider several safety precautions.

- Cardiovascular assessment: evaluate heart rate and blood pressure due to beta‑blocker effects. - Respiratory evaluation: avoid in patients with asthma or severe COPD. - Diabetes monitoring: beta‑blockers may mask hypoglycaemia symptoms. - Pregnancy and lactation: use only if potential benefit outweighs risk, as safety data are limited. - Concomitant ocular surgery: discontinue before procedures to reduce risk of delayed wound healing. - Store at room temperature: keep bottle tightly closed, protect from light and moisture.

Latanoprost + Timolol Generis can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers: additive bradycardia and hypotension. - Sympathomimetic eye drops (e.g., epinephrine): may reduce efficacy of timolol. - Antihypertensive agents (e.g., calcium channel blockers): increased risk of low blood pressure.

Moderate Interactions (Monitor Closely): - Carbonic anhydrase inhibitors (e.g., dorzolamide): potential additive IOP‑lowering effect. - Topical corticosteroids: may increase intra‑ocular pressure despite treatment. - NSAID eye drops: possible irritation when combined. - Anticholinergic drugs: may affect pupil size and ocular dynamics.